PRECISION BIOSCIENCES INC Quarterly Debt-to-equity in % from Q3 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Precision Biosciences Inc quarterly Debt-to-equity history and growth rate from Q3 2019 to Q3 2024.
  • Precision Biosciences Inc Debt-to-equity for the quarter ending September 30, 2024 was 239 %, a 37.4% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 239 -143 -37.4% Sep 30, 2024
Q2 2024 322 +13 +4.19% Jun 30, 2024
Q1 2024 479 +228 +90.9% Mar 31, 2024
Q4 2023 482 +270 +128% Dec 31, 2023
Q3 2023 382 +206 +117% Sep 30, 2023
Q2 2023 309 +158 +105% Jun 30, 2023
Q1 2023 251 +117 +87% Mar 31, 2023
Q4 2022 211 +46.8 +28.4% Dec 31, 2022
Q3 2022 176 -8.77 -4.74% Sep 30, 2022
Q2 2022 151 -52.1 -25.6% Jun 30, 2022
Q1 2022 134 -68.6 -33.8% Mar 31, 2022
Q4 2021 165 +32.3 +24.5% Dec 31, 2021
Q3 2021 185 +85.8 +86.4% Sep 30, 2021
Q2 2021 203 +122 +152% Jun 30, 2021
Q1 2021 203 +135 +197% Mar 31, 2021
Q4 2020 132 +37.1 +39.1% Dec 31, 2020
Q3 2020 99.2 -20.9 -17.4% Sep 30, 2020
Q2 2020 80.7 Jun 30, 2020
Q1 2020 68.4 Mar 31, 2020
Q4 2019 95.1 Dec 31, 2019
Q3 2019 120 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.